HEALTH AND MEDICINE COUNSEL for INTERSTITIAL CYSTITIS ASSOCIATION
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 5, 2022 | $10,000 | Replaced |
| 3rd Quarter - Report | Oct 5, 2022 | $10,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
FY22 L-HHS Appropriations Bill FY22 DoD Appropriations Bill FY22 MilCon-VA COVID-19 Supplemental Appropriations COVID-19 Legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANE CHRISTIANSEN | Legislative Consultant |
| DALE P DIRKS | Legislative Consultant |
| PHILIP GOGLAS | Legislative Consultant |
Health Issues HCR
IC Awareness & Education at CDC IC Research at NIH/DoD Pain Care/Management Policy Healthcare Reform, Patient Protections COVID-19 Relief Packages
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANE CHRISTIANSEN | Legislative Consultant |
| DALE P DIRKS | Legislative Consultant |
| PHILIP GOGLAS | Legislative Consultant |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.